v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
 6 Months Ended 188 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
OPERATING ACTIVITIES      
Net loss $ (4,753,676) $ (1,571,231) $ (53,611,630)
Depreciation     52,694
Stock-based compensation-product development costs 16,148 2,998 552,511
Stock-based compensation-interest expenses 3,280,929   16,611,913
Stock-based compensation-selling, general and administration 41,073 57,963 3,527,864
Stock-based compensation-professional fees 33,458 111,928 251,232
Stock-based compensation - market development     20,989
Non-cash imputed interest expenses 36,701 87,904 3,387,765
Accrued interest on line of credit 353,180 265,777 1,586,124
Equity instruments issued to settle liabilities     1,871,718
Other non-cash items included in net loss     341,629
Changes in operating assets and liabilities:      
(Increase) decrease in prepaid expenses 2,108 12,058 (2,280)
Increase in accounts payable and accrued liabilities 1,080 80,064 1,571,243
Increase in interest payable 287,368 252,912 5,025,375
Increase in advances payable   10,000 3,152,071
Income tax receivable     8,727
Net cash used in operating activities (701,631) (689,629) (15,652,055)
INVESTING ACTIVITIES      
Purchase of equipment     (43,078)
Net cash used in investing activities     (43,078)
FINANCING ACTIVITIES      
Proceeds from borrowings on line of credit 730,600 709,640 6,250,970
Proceeds from issuance of promissory notes     9,418,676
Proceeds from issuance of shares     1,512,403
Repayment of promissory notes payable     (970,879)
Expenditures to repurchase shares     (342,038)
Other financing activities     (115,472)
Net cash provided by financing activities 730,600 709,640 15,753,660
Change in cash 28,969 20,011 58,527
Cash, beginning of period 29,558 11,082  
Cash, end of period 58,527 31,093 58,527
Shares issued to settle liabilities $ 46,500 $ 30,000